Panagora Asset Management Inc Enzon Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

  • $19.7 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$0.23 - $0.31 $11,297 - $15,226
-49,119 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$0.23 - $0.28 $6,445 - $7,846
-28,022 Reduced 36.33%
49,119 $11,000
Q4 2018

Feb 14, 2019
BUY
$0.21 - $0.28 $2,565 - $3,421
12,218 Added 18.82%
77,141 $19,000
Q3 2018

Nov 13, 2018
BUY
$0.24 - $0.27 $6,055 - $6,812
25,232 Added 63.57%
64,923 $16,000
Q4 2017

Feb 14, 2018
SELL
$0.24 - $0.33 $536 - $737
-2,234 Reduced 5.33%
39,691 $11,000
Q3 2017

Nov 14, 2017
BUY
$0.24 - $0.39 $10,062 - $16,350
41,925
41,925 $10,000

About ENZON PHARMACEUTICALS, INC.

ENZN Quotes by TradingView
  • Ticker ENZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 74,214,600
  • Market Cap $11.1M
  • Description
  • Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
More about ENZN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email